Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples